Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Monday, Novavax, Inc. (NASDAQ:NVAX)'s Director, James F. Young, made a $203,000 buy of NVAX, purchasing 100,000 shares at a cost of $2.03 a piece. So far Young is in the green, up about 4.4% on their purchase based on today's trading high of $2.12. Novavax, Inc. is trading up about 1% on the day Thursday. This buy marks the first one filed by Young in the past year.
And also on Monday, EVP, Company Group Chairman Laizer Kornwasser bought $141,217 worth of Valeant Pharmaceuticals International Inc (NYSE:VRX), buying 2,000 shares at a cost of $70.61 each. Valeant Pharmaceuticals International Inc is trading up about 0.1% on the day Thursday. Investors can buy VRX even cheaper than Kornwasser did, with the stock changing hands as low as $69.89 at last check today -- that's 1.0% below Kornwasser's purchase price.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.